Journal of Lipid Research (Feb 2010)

Arylacetamide deacetylase attenuates fatty-acid-induced triacylglycerol accumulation in rat hepatoma cells

  • Vivien Lo,
  • Bruce Erickson,
  • Michaela Thomason-Hughes,
  • Kerry W.S. Ko,
  • Vernon W. Dolinsky,
  • Randy Nelson,
  • Richard Lehner

Journal volume & issue
Vol. 51, no. 2
pp. 368 – 377

Abstract

Read online

Mobilization of hepatic triacylglycerol stores provides substrates for mitochondrial β-oxidation and assembly of VLDLs; however, the identity of lipolytic enzymes involved in the regulation of this process remains largely unknown. Arylacetamide deacetylase (AADA) shares homology with hormone-sensitive lipase and therefore could potentially participate in hepatic lipid metabolism, including the regulation of hepatic triacylglycerol levels. We have established McArdle-RH7777 (rat hepatoma) cell lines stably expressing mouse AADA cDNA and performed metabolic labeling as well as lipid mass analyses. Expression of AADA cDNA in McArdle-RH7777 cells significantly reduced intracellular triacylglycerol levels and apolipoprotein B secretion and increased fatty acid oxidation.

Keywords